The pharmaceutical sector in the Gulf Cooperation Council and the impact of COVID-19

Countries in the GCC have been concentrating their efforts to develop and grow their healthcare and pharmaceutical sectors as an integral part of a ten-year vision to diversify the region’s economy and reduce its dependency on crude oil. While the global pandemic has presented the sector with new challenges, it has also created opportunities for growth in several directions, where it acted as a motive for countries to focus on local production and attract foreign investment in all health-related sectors.

Providing data and case studies on a country-by-country basis on key performance indicators such as pharmaceutical trade, market attractiveness and the impact of COVID-19, this report (download link below) serves as a valuable guide to the key pharma and healthcare markets in the GCC and how they are navigating current pandemic-related challenges.

To accompany the report, Informa Markets hosted a recent webinar, ‘GCC Pharma Market Outlook & Impact of COVID-19’ with a keynote address by His Excellency Dr. Amin Hussain al Almiri and contributions from Martin Tronquit, managing partner, Infomineo and Jean Dimca, vice president EMEA, Infomineo.

Click here to watch the entire webinar.